On September 6, Baltimore Orioles shortstop Cal Ripken, Jr. broke the consecutive-games-played record of 2,130 set by Lou Gehrig, the New York Yankees first-baseman who died in 1941 of amyotrophic lateral sclerosis (ALS) -- now known as Lou Gehrig's disease. To honor Gehrig, 260 one-time, $5,000 seats were sold along the first- and third-base sides of the field at Ripken's record-breaking game to raise $1.3 million to establish the Cal Ripken/Lou Gehrig Fund for Neuromuscular Research at Johns Hopkins University. The team kicked in another $700,000 to raise the total to $2 million. The money will support continued basic research on ALS at Hopkins, where the first modestly successful treat-ment for the disease -- a drug called Riluzole -- was recently developed. Riluzole, currently awaiting Food and Drug Administration approval, blocks release of the neurotransmitter glutamate....
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?